文献速递技术与安全US

利用电离辐射激活相变造影剂

Activation of Phase Change Contrast Agents Using Ionizing Radiation.
PubMed 文献 · J Ultrasound Med · 2021-12-06

本研究将Definity相变造影剂注入明胶体模,分别以0、30、50、100 Gy的X线剂量照射,照射后测量粒径分布与造影剂激活情况。Definity相变造影剂在50 Gy阈值下被激活,显微镜、T瓶目视检查和超声成像均可见变化,剂量超过50 Gy后似乎可进一步激活。结果提示Definity相变造影剂可能用于基于超声的辐射剂量测定。

要点

  • Definity相变造影剂在X线剂量达到50 Gy阈值时被激活。
  • 显微镜、T瓶目视检查和超声成像均可观察到激活后的变化。
  • 辐射剂量超过50 Gy后似乎可进一步激活相变造影剂。

核心结论

  • Definity相变造影剂可被X线激活,阈值50 Gy,提示其可能用于基于超声的辐射剂量测定。

研究设计与样本

  • 体外实验研究:将10 mL Definity相变造影剂(0.1 mL PCCA/mL)注入明胶体模,分别以0、30、50、100 Gy剂量照射,照射后测量粒径分布与激活情况。

关键影像表现/征象

  • 显微镜、T瓶目视检查和明胶体模超声成像均可见Definity相变造影剂激活后的变化。
  • Definity相变造影剂在50 Gy阈值下被激活,剂量超过50 Gy后似乎可进一步激活。

诊断标准与关键数值

  • Definity相变造影剂激活的辐射剂量阈值为50 Gy。

临床应用与阅片要点

  • 作者认为Definity相变造影剂可能用于基于超声的辐射剂量测定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The feasibility of activating phase change contrast agents (PCCA) made from Definity (Lantheus Medical Imaging) using X-rays was investigated. A 10 mL of Definity PCCA (0.1 mL PCCA/mL) were injected into gelatin phantoms and irradiated using doses of 0, 30, 50, and 100 Gy. Size distribution and PCCA activation were measured after irradiation. Definity PCCAs were activated at a threshold of 50 Gy. Changes were visible with microscopy, visual inspection of T-flasks, and ultrasound imaging of gelatin phantoms. Moreover, increasing the radiation dose above 50 Gy appeared to further activate PCCA. These results indicate Definity PCCAs may be useful for ultrasound-based radiation dosimetry.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Falatah, Lacerda, Chaga, et al. Activation of Phase Change Contrast Agents Using Ionizing Radiation. J Ultrasound Med. 2021. PMID: 34866197. doi:10.1002/jum.15910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。